These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38704598)
1. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy. Toal M; Fergie R; Quinn M; Hill C; O'Neill C; Maxwell AP Syst Rev; 2024 May; 13(1):122. PubMed ID: 38704598 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970 [TBL] [Abstract][Full Text] [Related]
3. Repeat renal biopsy improves the Oxford classification-based prediction of immunoglobulin A nephropathy outcome. Jullien P; Laurent B; Berthoux F; Masson I; Dinic M; Claisse G; Thibaudin D; Mariat C; Alamartine E; Maillard N Nephrol Dial Transplant; 2020 Jul; 35(7):1179-1186. PubMed ID: 30445530 [TBL] [Abstract][Full Text] [Related]
4. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients. Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434 [TBL] [Abstract][Full Text] [Related]
5. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy. Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014 [TBL] [Abstract][Full Text] [Related]
6. A validation study of crescents in predicting ESRD in patients with IgA nephropathy. Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226 [TBL] [Abstract][Full Text] [Related]
7. The MEST score provides earlier risk prediction in lgA nephropathy. Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ; Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049 [TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients. Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046 [TBL] [Abstract][Full Text] [Related]
9. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study. Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy. Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222 [TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
12. A Validation Study Comparing Risk Prediction Models of IgA Nephropathy. Ouyang Y; Zhao Z; Li G; Luo H; Xu F; Shao L; Chen Z; Yu S; Jin Y; Xu J; Shi M; Hussain HMJ; Du W; Fang Z; Pan X; Wang W; Xie J; Chen N Front Immunol; 2021; 12():753901. PubMed ID: 34721428 [TBL] [Abstract][Full Text] [Related]
13. A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility. Ali I; Donne RL; Kalra PA BMC Nephrol; 2021 May; 22(1):194. PubMed ID: 34030639 [TBL] [Abstract][Full Text] [Related]
14. The use of the Oxford classification of IgA nephropathy to predict renal survival. Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791 [TBL] [Abstract][Full Text] [Related]
15. Clinical importance of the updated Oxford classification in allograft IgA nephropathy. Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369 [TBL] [Abstract][Full Text] [Related]
16. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y; J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645 [TBL] [Abstract][Full Text] [Related]
17. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258 [TBL] [Abstract][Full Text] [Related]
18. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients. Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850 [TBL] [Abstract][Full Text] [Related]
19. Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy. Chen T; Li X; Li Y; Xia E; Qin Y; Liang S; Xu F; Liang D; Zeng C; Liu Z Am J Kidney Dis; 2019 Sep; 74(3):300-309. PubMed ID: 31031086 [TBL] [Abstract][Full Text] [Related]
20. Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease. Winnicki E; McCulloch CE; Mitsnefes MM; Furth SL; Warady BA; Ku E JAMA Pediatr; 2018 Feb; 172(2):174-180. PubMed ID: 29255845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]